[{"Assets_0_FY_USD":3850504000.0,"EarningsPerShareBasic_1_FY_USD":-0.7,"EarningsPerShareBasic_4_FY_USD":0.96,"EarningsPerShareDiluted_1_FY_USD":-0.7,"EarningsPerShareDiluted_4_FY_USD":0.95,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":216433000.0,"NetIncomeLoss_1_FY_USD":-20600000.0,"NetIncomeLoss_4_FY_USD":28125000.0,"StockholdersEquity_0_FY_USD":2586759000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":29646000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":29440000.0,"Ticker":"BIO","CIK":"12208","name":"BIO RAD LABORATORIES INC","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20170301"}]